Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.94
1.87
NAV
₹42.47
₹42.02
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹2891.76 Cr
₹6293.14 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
2.45%
6.10%
3 Year
21.25%
26.51%
5 Year
13.37%
15.90%
Equity
97.66%
97.62%
Cash
2.34%
2.35%
Top 10 Holdings
Ipca Laboratories Ltd. | 9.39% |
Sun Pharmaceutical Industries Ltd. | 9.33% |
Cipla Ltd. | 7.68% |
Globus Medical Inc | 7.58% |
Illumina Inc. (USA) | 6.47% |
Laurus Labs Ltd. | 6.29% |
Sai Life Sciences Ltd. | 6.02% |
Gland Pharma Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.00% |
Alembic Pharmaceuticals Ltd. | 3.28% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018
